EP 1458352 A1 20040922 - SOLID DOSE MICRO IMPLANT
Title (en)
SOLID DOSE MICRO IMPLANT
Title (de)
FESTDOSIS-MIKROIMPLANTAT
Title (fr)
MICRO IMPLANT A DOSE SOLIDE
Publication
Application
Priority
- DK 0200865 W 20021217
- DK PA200101901 A 20011218
Abstract (en)
[origin: WO03051328A1] A solid pharmaceutical composition for parenteral administration comprising an inner matrix comprising at least one therapeutic agent, and a biodegradable, and water-impermeable coating covering part of the surface of said composition,wherein said inner matrix disintegrates upon contact with animal tissue or tissue fluids. The coating is made from a material selected from the group consisting of polyesters such as polyglycolides, polylactides and polylactic polyglycolic acid copolymers (PLGA) etc. The innermatrix may comprise a binder, e.g. mannitol, and the active agent may comprise insulin.
IPC 1-7
IPC 8 full level
A61K 9/30 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/32 (2006.01); A61K 9/36 (2006.01); A61K 38/21 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 38/43 (2006.01); A61K 45/00 (2006.01); A61P 3/10 (2006.01); A61P 5/00 (2006.01); A61P 7/00 (2006.01)
CPC (source: EP)
A61K 9/0024 (2013.01); A61K 9/0092 (2013.01); A61P 3/10 (2017.12); A61P 5/00 (2017.12); A61P 7/00 (2017.12)
Citation (search report)
See references of WO 03051328A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03051328 A1 20030626; AU 2002351739 A1 20030630; EP 1458352 A1 20040922; JP 2005517651 A 20050616; JP 2010280709 A 20101216; JP 4615862 B2 20110119
DOCDB simple family (application)
DK 0200865 W 20021217; AU 2002351739 A 20021217; EP 02787456 A 20021217; JP 2003552261 A 20021217; JP 2010181647 A 20100816